Keywords
Last Name
Institution

MICHAEL T JARRATT

TitleClinical Associate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Dermatology
AddressOne Baylor Plaza
Houston TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Jarratt MT, Jones TM, Chang-Lin JE, Tong W, Berk DR, Lin V, Kaoukhov A. Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris. J Drugs Dermatol. 2016 Oct 1; 15(10):1250-1259. PMID: 27741344.
      View in: PubMed
    2. Stein Gold LF, Jarratt MT, Bucko AD, Grekin SK, Berlin JM, Bukhalo M, Weiss JS, Berk DR, Chang-Lin JE, Lin V, Kaoukhov A. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials. J Drugs Dermatol. 2016 May 1; 15(5):553-61. PMID: 27168264.
      View in: PubMed
    3. Pariser DM, Eichenfield LF, Bukhalo M, Waterman G, Jarratt M. Photodynamic therapy with methyl aminolaevulinate 80 mg g(-1) for severe facial acne vulgaris: a randomized vehicle-controlled study. Br J Dermatol. 2016 Apr; 174(4):770-7. PMID: 26663215.
      View in: PubMed
    4. Anderson L, Jarratt M, Schmieder G, Shumack S, Katsamas J, Welburn P. Tolerability and Pharmacokinetics of Ingenol Mebutate 0.05% Gel Applied to Treatment Areas up to 100cm(2) on the Forearm(s) of Patients with Actinic Keratosis. J Clin Aesthet Dermatol. 2014 Dec; 7(12):19-29. PMID: 25584134; PMCID: PMC4285446.
    5. Toledo-Bahena ME, Bucko A, Ocampo-Candiani J, Herz-Ruelas ME, Jones TM, Jarratt MT, Pollak RA, Zane LT. The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis. J Drugs Dermatol. 2014 Sep; 13(9):1124-32. PMID: 25226015.
      View in: PubMed
    6. Fowler J, Tan J, Jackson JM, Meadows K, Jones T, Jarratt M, Leoni M. Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema. J Eur Acad Dermatol Venereol. 2015 Mar; 29(3):474-81. PMID: 25074756.
      View in: PubMed
    7. Jarratt M, Jones T, Adelglass J, Bucko A, Pollak R, Roman-Miranda A, Olin JT, Swinyer L. Efficacy and safety of once-daily luliconazole 1% cream in patients ?12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study. J Drugs Dermatol. 2014 Jul; 13(7):838-46. PMID: 25007368.
      View in: PubMed
    8. Jackson JM, Fowler J, Moore A, Jarratt M, Jones T, Meadows K, Steinhoff M, Rudisill D, Leoni M. Improvement in facial erythema within 30 minutes of initial application of brimonidine tartrate in patients with rosacea. J Drugs Dermatol. 2014 Jun; 13(6):699-704. PMID: 24918560.
      View in: PubMed
    9. Jones TM, Jarratt MT, Mendez-Moguel I, Paz N, Grekin SK, Cognata Smith C, Kaur M. A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ? 12 years with tinea cruris. J Drugs Dermatol. 2014 Jan; 13(1):32-8. PMID: 24385117.
      View in: PubMed
    10. Jarratt M, Siu WJ, Yamakawa E, Kodera N, Pillai R, Smith K. Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis. J Drugs Dermatol. 2013 Sep; 12(9):1010-6. PMID: 24002148.
      View in: PubMed
    11. Fowler J, Jackson M, Moore A, Jarratt M, Jones T, Meadows K, Steinhoff M, Rudisill D, Leoni M. Efficacy and safety of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of two randomized, double-blind, and vehicle-controlled pivotal studies. J Drugs Dermatol. 2013 Jun 1; 12(6):650-6. PMID: 23839181.
      View in: PubMed
    12. Jarratt M, Jones T, Kempers S, Rich P, Morton K, Nakamura N, Tavakkol A. Luliconazole for the treatment of interdigital tinea pedis: A double-blind, vehicle-controlled study. Cutis. 2013 Apr; 91(4):203-10. PMID: 23763082.
      View in: PubMed
    13. Jarratt M, Werner CP, Alió Saenz AB. Tazarotene foam versus tazarotene gel: a randomized relative bioavailability study in acne vulgaris. Clin Drug Investig. 2013 Apr; 33(4):283-9. PMID: 23456673.
      View in: PubMed
    14. Schmieder GJ, Huang EY, Jarratt M. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period. J Drugs Dermatol. 2012 Dec; 11(12):1483-9. PMID: 23377520.
      View in: PubMed
    15. Kircik L, Jones TM, Jarratt M, Flack MR, Ijzerman M, Ciotti S, Sutcliffe J, Boivin G, Stanberry LR, Baker JR. Treatment with a novel topical nanoemulsion (NB-001) speeds time to healing of recurrent cold sores. J Drugs Dermatol. 2012 Aug; 11(8):970-7. PMID: 22859243.
      View in: PubMed
    16. Jarratt MT, Brundage T. Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study. J Drugs Dermatol. 2012 Mar; 11(3):318-26. PMID: 22395582.
      View in: PubMed
    17. Fowler J, Jarratt M, Moore A, Meadows K, Pollack A, Steinhoff M, Liu Y, Leoni M. Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. Br J Dermatol. 2012 Mar; 166(3):633-41. PMID: 22050040; PMCID: PMC3711536.
    18. Tan J, Stein Gold L, Schlessinger J, Brodell R, Jones T, Cruz A, Kerrouche N, Jarratt M. Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris. J Drugs Dermatol. 2012 Feb; 11(2):174-80. PMID: 22270198.
      View in: PubMed
    19. Poulin Y, Sanchez NP, Bucko A, Fowler J, Jarratt M, Kempers S, Kerrouche N, Dhuin JC, Kunynetz R. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. Br J Dermatol. 2011 Jun; 164(6):1376-82. PMID: 21457209.
      View in: PubMed
    20. Pariser D, Bucko A, Fried R, Jarratt MT, Kempers S, Kircik L, Lucky AW, Rafal E, Rendon M, Weiss J, Wilson DC, Rossi AB, Ramaswamy R, Nighland M. Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen. J Drugs Dermatol. 2010 Jul; 9(7):805-13. PMID: 20677537.
      View in: PubMed
    21. Eichenfield LF, Jarratt M, Schlessinger J, Kempers S, Manna V, Hwa J, Liu Y, Graeber M. Adapalene 0.1% lotion in the treatment of acne vulgaris: results from two placebo-controlled, multicenter, randomized double-blind, clinical studies. J Drugs Dermatol. 2010 Jun; 9(6):639-46. PMID: 20645525.
      View in: PubMed
    22. Del Rosso JQ, Bruce S, Jarratt M, Menter A, Staedtler G. Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea. J Drugs Dermatol. 2010 Jun; 9(6):607-13. PMID: 20645521.
      View in: PubMed
    23. Foley P, Freeman M, Menter A, Siller G, El-Azhary RA, Gebauer K, Lowe NJ, Jarratt MT, Murrell DF, Rich P, Pariser DM, Oseroff AR, Barnetson R, Anderson C, Kossard S, Gibson LE, Tope WD. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. Int J Dermatol. 2009 Nov; 48(11):1236-45. PMID: 20064185.
      View in: PubMed
    24. Friedewald VE, Cather JC, Gelfand JM, Gordon KB, Gibbons GH, Grundy SM, Jarratt MT, Krueger JG, Ridker PM, Stone N, Roberts WC. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol. 2008 Dec 15; 102(12):1631-43. PMID: 19064017.
      View in: PubMed
    25. Piette WW, Taylor S, Pariser D, Jarratt M, Sheth P, Wilson D. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris. Arch Dermatol. 2008 Dec; 144(12):1564-70. PMID: 19075138.
      View in: PubMed
    26. Pariser D, Loss R, Jarratt M, Abramovits W, Spencer J, Geronemus R, Bailin P, Bruce S. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study. J Am Acad Dermatol. 2008 Oct; 59(4):569-76. PMID: 18707799.
      View in: PubMed
    27. Boguniewicz M, Zeichner JA, Eichenfield LF, Hebert AA, Jarratt M, Lucky AW, Paller AS. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. J Pediatr. 2008 Jun; 152(6):854-9. PMID: 18492531.
      View in: PubMed
    28. Abramovits W, Hebert AA, Boguniewicz M, Kempers SE, Tschen E, Jarratt MT, Lucky AW, Cornelison RL, Swinyer LJ, Jones TM. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults. J Dermatolog Treat. 2008; 19(6):327-32. PMID: 18728923.
      View in: PubMed
    29. Jarratt MT, Clark SD, Savin RC, Swinyer LJ, Safley CF, Brodell RT, Yu K. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis. Cutis. 2006 Nov; 78(5):348-54. PMID: 17186795.
      View in: PubMed
    30. Torok HM, Webster G, Dunlap FE, Egan N, Jarratt M, Stewart D. Combination sodium sulfacetamide 10% and sulfur 5% cream with sunscreens versus metronidazole 0.75% cream for rosacea. Cutis. 2005 Jun; 75(6):357-63. PMID: 16047874.
      View in: PubMed
    31. Jarratt M. Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines. Cutis. 2004 Nov; 74(5):319-22. PMID: 15605971.
      View in: PubMed
    32. DiGiovanna JJ, Langman CB, Tschen EH, Jones T, Menter A, Lowe NJ, Eichenfield L, Hebert AA, Pariser D, Savin RP, Smith SR, Jarratt M, Rodriguez D, Chalker DK, Kempers S, Ling M, Rafal ES, Sullivan S, Kang S, Shah LP, Wu E, Newhouse J, Pak J, Eberhardt DR, Bryce GF, McLane JA, Ondovik M, Chin C, Khoo KC, Rich P. Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne. J Am Acad Dermatol. 2004 Nov; 51(5):709-17. PMID: 15523348.
      View in: PubMed
    33. Kempers S, Boguniewicz M, Carter E, Jarratt M, Pariser D, Stewart D, Stiller M, Tschen E, Chon K, Wisseh S, Abrams B. A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis. J Am Acad Dermatol. 2004 Oct; 51(4):515-25. PMID: 15389185.
      View in: PubMed
    34. Jarratt M, Breneman D, Gottlieb AB, Poulin Y, Liu Y, Foley V. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis. J Drugs Dermatol. 2004 Jul-Aug; 3(4):367-73. PMID: 15303780.
      View in: PubMed
    35. Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ, Yamauchi PS. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol. 2003 Feb; 48(2):227-32. PMID: 12582393.
      View in: PubMed
    36. Thiboutot D, Jarratt M, Rich P, Rist T, Rodriguez D, Levy S. A randomized, parallel, vehicle-controlled comparison of two erythromycin/benzoyl peroxide preparations for acne vulgaris. Clin Ther. 2002 May; 24(5):773-85. PMID: 12075945.
      View in: PubMed
    37. Dahl MV, Jarratt M, Kaplan D, Tuley MR, Baker MD. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol. 2001 Nov; 45(5):723-30. PMID: 11606923.
      View in: PubMed
    38. Rizer RL, Sklar JL, Whiting D, Bucko A, Shavin J, Jarratt M. Clindamycin phosphate 1% gel in acne vulgaris. Adv Ther. 2001 Nov-Dec; 18(6):244-52. PMID: 11841194.
      View in: PubMed
    39. Thiboutot D, Gold MH, Jarratt MT, Kang S, Kaplan DL, Millikan L, Wolfe J, Loesche C, Baker M. Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris. Cutis. 2001 Oct; 68(4 Suppl):10-9. PMID: 11845943.
      View in: PubMed
    40. Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski DJ, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol. 2001 Aug; 45(2):196-207. PMID: 11464180.
      View in: PubMed
    41. Strauss JS, Leyden JJ, Lucky AW, Lookingbill DP, Drake LA, Hanifin JM, Lowe NJ, Jones TM, Stewart DM, Jarratt MT, Katz I, Pariser DM, Pariser RJ, Tschen E, Chalker DK, Rafal ES, Savin RP, Roth HL, Chang LK, Baginski DJ, Kempers S, McLane J, Eberhardt D, Leach EE, Bryce G, Hong J. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol. 2001 Aug; 45(2):187-95. PMID: 11464179.
      View in: PubMed
    42. Leyden JJ, Hickman JG, Jarratt MT, Stewart DM, Levy SF. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cutan Med Surg. 2001 Jan-Feb; 5(1):37-42. PMID: 11281433.
      View in: PubMed
    43. Ling MR, Swinyer LJ, Jarratt MT, Falo L, Monroe EW, Tharp M, Kalivas J, Weinstein GD, Asarch RG, Drake L, Martin AG, Leyden JJ, Cook J, Pariser DM, Pariser R, Thiers BH, Lebwohl MG, Babel D, Stewart DM, Eaglstein WH, Falanga V, Katz HI, Bergfeld WF, Hanifin JM, Young MR, et al. Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. J Am Acad Dermatol. 1998 Jun; 38(6 Pt 2):S95-102. PMID: 9631991.
      View in: PubMed
    44. Lucky AW, Cullen SI, Funicella T, Jarratt MT, Jones T, Reddick ME. Double-blind, vehicle-controlled, multicenter comparison of two 0.025% tretinoin creams in patients with acne vulgaris. J Am Acad Dermatol. 1998 Apr; 38(4):S24-30. PMID: 9555823.
      View in: PubMed
    45. Lucky AW, Cullen SI, Jarratt MT, Quigley JW. Comparative efficacy and safety of two 0.025% tretinoin gels: results from a multicenter double-blind, parallel study. J Am Acad Dermatol. 1998 Apr; 38(4):S17-23. PMID: 9555822.
      View in: PubMed
    46. Ellis CN, Berberian B, Sulica VI, Dodd WA, Jarratt MT, Katz HI, Prawer S, Krueger G, Rex IH, Wolf JE. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol. 1993 Sep; 29(3):438-42. PMID: 7688774.
      View in: PubMed
    47. Tasjian D, Jarratt M. Familial acanthosis nigricans. Arch Dermatol. 1984 Oct; 120(10):1351-4. PMID: 6486848.
      View in: PubMed
    48. Nelson DA, Jarratt M. Angiolymphoid hyperplasia with eosinophilia. Pediatr Dermatol. 1984 Jan; 1(3):210-4. PMID: 6494065.
      View in: PubMed
    49. Jarratt M, Hill M, Smiles K. Topical protection against long-wave ultraviolet A. J Am Acad Dermatol. 1983 Sep; 9(3):354-60. PMID: 6605370.
      View in: PubMed
    50. Couch RB, Jarratt MT, Greenberg SB, Jackson D. Genital herpes: an epidemic disease. Heart Lung. 1983 May; 12(3):320-4. PMID: 6551383.
      View in: PubMed
    51. Jarratt M. Herpes simplex infection. Arch Dermatol. 1983 Feb; 119(2):99-103. PMID: 6297412.
      View in: PubMed
    52. Stern JK, Wolf JE, Jarratt M. Benign neonatal hemangiomatosis. J Am Acad Dermatol. 1981 Apr; 4(4):442-5. PMID: 7229148.
      View in: PubMed
    53. Peterson AO, Jarratt M. Annular erythema of infancy. Arch Dermatol. 1981 Mar; 117(3):145-8. PMID: 7212726.
      View in: PubMed
    54. Peterson AO, Jarratt M. Pruritus and nonspecific nodules preceding myelomonocytic leukemia. J Am Acad Dermatol. 1980 Jun; 2(6):496-8. PMID: 6931110.
      View in: PubMed
    55. Cox GF, Jarratt M. Linear porokeratosis and other linear cutaneous eruptions of childhood. Am J Dis Child. 1979 Dec; 133(12):1258-9. PMID: 517477.
      View in: PubMed
    56. McCarty JR, Jarratt MT. Topical phosphonoacetic acid treatment of cutaneous herpes simplex infections in the guinea pig. J Am Acad Dermatol. 1979 Sep; 1(3):244-8. PMID: 512074.
      View in: PubMed
    57. Jarratt M, Bybee JD, Ramsdell W. Eosinophilic fasciitis: an early variant of scleroderma. J Am Acad Dermatol. 1979 Sep; 1(3):221-6. PMID: 512071.
      View in: PubMed
    58. Jarratt M, Ramsdell W. Infantile acropustulosis. Arch Dermatol. 1979 Jul; 115(7):834-6. PMID: 453890.
      View in: PubMed
    59. Jarratt M, Smith R, Knox JM. Therapy of herpes simplex infection. Int J Dermatol. 1979 Jun; 18(5):357-61. PMID: 381223.
      View in: PubMed
    60. Picou K, Batres E, Jarratt M. Botryomycosis. A bacterial cause of mycetoma. Arch Dermatol. 1979 May; 115(5):609-10. PMID: 443838.
      View in: PubMed
    61. Picou KA, Jarratt MT. Persistent subcutaneous abscesses following Pseudomonas sepsis. Treatment by surgical incision and drainage. Arch Dermatol. 1979 Apr; 115(4):459-60. PMID: 434870.
      View in: PubMed
    62. Robertson DB, McCarty JR, Jarratt M. Treatment of psoriasis with 8-methoxypsoralen and sunlight. South Med J. 1978 Nov; 71(11):1345-9. PMID: 362536.
      View in: PubMed
    63. Taunton OD, Yeshurun D, Jarratt M. Progressive nodular histiocytoma. Arch Dermatol. 1978 Oct; 114(10):1505-8. PMID: 214042.
      View in: PubMed
    64. Jarratt M. Viral infections of the skin. Herpes simplex, herpes zoster, warts, and molluscum contagiosum. Pediatr Clin North Am. 1978 May; 25(2):339-55. PMID: 353674.
      View in: PubMed
    65. McCarty JR, Raimer SS, Jarratt M. Toxic epidermal necrolysis from graft-vs-host disease. Occurrence in a patient with thymic hypoplasia. Am J Dis Child. 1978 Mar; 132(3):282-4. PMID: 24335.
      View in: PubMed
    66. Hazelrigg DE, Duncan WC, Jarratt M. Twenty-nail dystrophy of childhood. Arch Dermatol. 1977 Jan; 113(1):73-5. PMID: 831628.
      View in: PubMed
    67. Jarratt M. Drug photosensitization. Int J Dermatol. 1976 Jun; 15(5):317-23. PMID: 1279061.
      View in: PubMed
    68. Jarratt M, Rudolph A. Letter: Toxic epidermal necrolysis. Arch Dermatol. 1975 Jan; 111(1):132. PMID: 1119819.
      View in: PubMed
    69. Jarratt M, Hubler WR. Herpes genitalis and aseptic meningitis. Arch Dermatol. 1974 Nov; 110(5):771-2. PMID: 4370983.
      View in: PubMed
    70. Jarratt MT, Hubler WR, Knox JM, Melnick JL. Letter: Dye-photoinactivation and herpes simplex. Arch Dermatol. 1974 Apr; 109(4):570. PMID: 4819116.
      View in: PubMed
    71. Jarratt MT, Spark RF, Arndt KA. The effects of intradermal steroids on the pituitary-adrenal axis and the skin. J Invest Dermatol. 1974 Apr; 62(4):463-6. PMID: 4820688.
      View in: PubMed
    72. Hubler WR, Felber TD, Troll D, Jarratt M. Guinea pig model for cutaneous herpes simplex virus infection. J Invest Dermatol. 1974 Feb; 62(2):92-5. PMID: 4359403.
      View in: PubMed
    JARRATT's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _